Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Chief Executive Officer bought 30,000 shares at $3.22 ($96,600)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award President, COO & CFO acquired 1,117 shares (grant or award)
  8. 4 Option exercise Director acquired 16,000 shares (option exercise)
  9. 4 Option exercise Director acquired 120,000 shares (option exercise)
  10. 4 Open-market sale Chief Executive Officer sold 11,800 shares at $3.57 ($42,126)
  11. 4 Open-market buy President, COO & CFO bought 5,500 shares at $3.64 ($20,020)
  12. 4 Grant or award President, COO & CFO acquired 865 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Other acquisition President, COO & CFO acquired 1,069 shares (other)
  19. 4 Option exercise Director acquired 40,000 shares (option exercise)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 491,900 shares (to pay taxes)

Page 4 of 24 · 471 filings